Department of Urology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Urology. 2010 Oct;76(4):946-51. doi: 10.1016/j.urology.2010.03.055. Epub 2010 Aug 13.
Bilateral Wilms' tumors represent a therapeutic challenge. The primary aim of management is eradication of the neoplasm and preservation of renal function. We present our experience in the management of such cases in a single-center experience.
This was a retrospective study of 22 patients with histologically proven bilateral nephroblastoma who were treated from 1993 to 2008 at our center. Of the 22 patients, 12 were girls and 10 were boys, with a median age of 3 years (range 1-9); 19 had a synchronous presentation and 3 a metachronous presentation. Of the 22 patients, 6 underwent initial surgical resection followed by chemotherapy and 16 underwent initial biopsy and preoperative chemotherapy. The final oncologic and renal outcomes were assessed.
The median follow-up period was 3 years (range 1-11). Of the 22 patients, 8 died, for an overall survival rate of 63.5%. The survival for the initial chemotherapy and initial surgery groups was essentially similar. Of all the variables studied, unfavorable histologic findings had a significant negative effect on survival. Of the 5 patients with unfavorable histologic findings, 4 died during the follow-up period. The median volume of preserved renal parenchyma was 40%. All patients had good renal function during follow-up, except for 1 patient who had undergone bilateral nephrectomy.
Bilateral Wilms' tumors impose 2 conflicting issues: elimination of the pathology and preservation of the renal function. Currently, treatment regimens involving initial chemotherapy followed by conservative surgery can achieve these goals in an important proportion of patients.
双侧 Wilms 瘤是一种治疗挑战。管理的主要目标是消除肿瘤并保留肾功能。我们在单中心经验中介绍了此类病例的管理经验。
这是对 1993 年至 2008 年在我们中心接受治疗的 22 例组织学证实为双侧肾母细胞瘤患者的回顾性研究。22 例患者中,女孩 12 例,男孩 10 例,中位年龄 3 岁(范围 1-9);19 例为同步表现,3 例为异时表现。22 例患者中,6 例行初始手术切除,继以化疗,16 例行初始活检和术前化疗。评估最终的肿瘤学和肾脏结果。
中位随访时间为 3 年(范围 1-11)。22 例患者中,8 例死亡,总生存率为 63.5%。初始化疗和初始手术组的生存率基本相似。在所有研究的变量中,不良组织学发现对生存率有显著的负面影响。在 5 例有不良组织学发现的患者中,有 4 例在随访期间死亡。保留的肾实质体积中位数为 40%。除 1 例患者行双侧肾切除术外,所有患者在随访期间肾功能均良好。
双侧 Wilms 瘤带来了两个相互冲突的问题:消除病变和保留肾功能。目前,包括初始化疗后行保守手术的治疗方案可以在很大一部分患者中实现这些目标。